Two Sigma Securities, LLC Bausch Health Companies Inc. Call Options Transaction History

Two Sigma Securities, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $195,500 - $246,585	-8,500 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $212,840 - $255,510	8,500 New	8,500 $237,000
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $512,880 - $825,120	-24,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $367,440 - $506,880	24,000 New	24,000 $499,000
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $668,162 - $1.03 Million	-50,200 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$12.98 - $30.25 $777,502 - $1.81 Million	-59,900 Reduced 54.41%	50,200 $778,000
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $171,899 - $290,199	9,100 Added 9.01%	110,100 $3.29 Million
Q2 2019 Aug 14, 2019	BUY	$20.52 - $26.45 $1.42 Million - $1.84 Million	69,400 Added 219.62%	101,000 $2.55 Million
Q1 2019 May 15, 2019	SELL	$20.23 - $26.29 $952,833 - $1.24 Million	-47,100 Reduced 59.85%	31,600 $781,000
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $1,764 - $2,832	100 Added 0.13%	78,700 $1.45 Million
Q3 2018 Nov 14, 2018	BUY	$20.64 - $25.67 $1.62 Million - $2.02 Million	78,600 New	78,600 $2.02 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.